This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Media Statement: Robert Moussa, President And CEO, Dilon Diagnostics

NEWPORT NEWS, Va., Aug. 26 /PRNewswire/ -- Radiation in any form brings risk. Medical radiation as a screening, diagnostic or treatment tool is designed with safeguards in mind to minimize the risk and maximize the benefit of the test or treatment. For instance, if a patient presents with a breast lump that can be felt but not viewed with mammography or ultrasound, medical professionals must employ the most appropriate diagnostic tools that identify potential cancer. By not doing so, the risk of missing cancers can be deadly.

Breast-Specific Gamma Imaging (BSGI) is a molecular breast-imaging exam that reveals metabolic activity, which is useful in the diagnostic work-up of a patient with suspected breast cancer. BSGI works on a cellular level that, with the aid of a radiopharmaceutical, identifies areas of increased activity that may indicate disease. BSGI is a complementary tool to mammography (an anatomical exam). In essence, mammography shows what the breast looks like and BSGI shows activity of the breast tissue.

A recent article in the journal Radiology by R. Edward Hendrick, Ph.D., makes a dubious comparison regarding the dose of radiation screening mammography (X-ray) to the radiation used in advanced diagnostic tools, such as BSGI and positron emission mammography (PEM). Dr. James Johnston, Professor of Radiologic Science at Midwestern State University in Texas notes that while this article provides important facts and useful information, the primary message should be one of appropriate use and not condemning any one modality based on an apples and oranges comparison.

As stated in the article, "a single BSGI or PEM is comparable in terms of dose and lifetime risk of cancer induction to a single chest, abdominal, or pelvic CT examination," which are ordered thousands of times each day in the U.S. Furthermore, the same radiopharmaceuticals used in BSGI and PEM studies are used in many other nuclear medicine exams every day such as cardiac stress tests and bone scans, in similar or higher radiation doses. And as Dr. Hendrick noted in the Radiology article, in most cases the balance of risk to benefit favors the use of imaging, but it is up to the patient in consultation with the physician to make an informed decision.

BSGI has led to the detection of countless breast cancers in patients across the U.S. and around the world. Many of these cancers were missed by mammography and ultrasound. BSGI is a recognized medical procedure that utilizes a radiopharmaceutical approved by the FDA, with guidelines for use by the Society of Nuclear Medicine, specifically, "Procedure Guidelines for Breast Scintigraphy with Breast-Specific Gamma Cameras."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $118.33 -2.40%
FB $93.73 -0.30%
GOOG $627.60 0.32%
TSLA $258.77 -2.80%
YHOO $36.45 -0.60%

Markets

Chart of I:DJI
DOW 17,504.19 -185.67 -1.05%
S&P 500 2,087.46 -16.38 -0.78%
NASDAQ 5,084.4470 -43.8340 -0.85%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs